Impaired Kidney Function Associated with Increased Risk of Side Effects in Patients with Small Vessel Vasculitis Treated with Rituximab as an Induction Therapy

Rituximab (RTX), a monoclonal antibody against the CD20 molecule, is used as an induction therapy in the treatment of small vessel vasculitis (SVV). The aim of the study was to evaluate the efficacy and safety of RTX induction therapy for refractory SVV. A retrospective analysis of 20 patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rymarz, Aleksandra, Matyjek, Anna, Sułek-Jakóbczyk, Magdalena, Mosakowska, Magdalena, Niemczyk, Stanisław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920022/
https://www.ncbi.nlm.nih.gov/pubmed/33669267
http://dx.doi.org/10.3390/jcm10040786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920022/
https://www.ncbi.nlm.nih.gov/pubmed/33669267
http://dx.doi.org/10.3390/jcm10040786

Ejemplares similares